PHIO
Phio Pharmaceuticals Corp
NASDAQ: PHIO · HEALTHCARE · BIOTECHNOLOGY
$1.22
+3.39% today
Updated 2026-04-30
Market cap
$13.94M
P/E ratio
—
P/S ratio
48.01x
EPS (TTM)
$-1.45
Dividend yield
—
52W range
$1 – $3
Volume
0.3M
Phio Pharmaceuticals Corp (PHIO) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-70.00%
ROA
-42.30%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2011 | — | $-10.22M | — | — | — |
| 2012 | $97000.00 | $-12.88M | -13,276.29% | -13,376.29% | -13,278.35% |
| 2013 | $399000.00 | $-20.93M | -4,323.81% | -5,250.38% | -5,244.36% |
| 2014 | $71000.00 | $-8.80M | -7,900.00% | -12,430.99% | -12,394.37% |
| 2015 | $34000.00 | $-10.22M | -20,267.65% | -30,108.82% | -30,067.65% |
| 2016 | $19000.00 | $-8.99M | -28,400.00% | -47,447.37% | -47,336.84% |
| 2017 | $15000.00 | $-12.45M | -35,700.00% | -93,746.67% | -83,013.33% |
| 2018 | $138000.00 | $-7.36M | 100.00% | -5,336.23% | -5,333.33% |
| 2019 | $21000.00 | $-8.84M | 100.00% | -42,795.24% | -42,100.00% |
| 2020 | $4362.00 | $-8.79M | -85,190.28% | -201,581.84% | -201,604.77% |
| 2021 | $0.00 | $-13.21M | — | — | — |
| 2022 | $0.00 | $-11.30M | — | — | — |
| 2023 | $0.00 | $-10.83M | — | — | — |
| 2024 | $0.00 | $-7.15M | — | — | — |
| 2025 | $0.00 | $-8.70M | — | — | — |